FibroBiologics CFO Acquires 70,000 Shares as Company Sees Volatile Gains
FibroBiologics Chief Financial Officer Jason Davis purchased 70,000 shares of the company’s common stock on March 2, 2026, spending $28,973 in total. The transaction occurred as the biotech's shares experienced pronounced short-term gains and the company advanced clinical and intellectual property milestones. Analysts and market data show strong mo…